Percutaneous ablation for HCC eligible to transplantation: providing more opportunities of remission in the context of graft shortage

Liver transplantation (LT) is still considered as the best treatment for small HCC as compared to other curative therapeutic options such as resection and ablation, at least in theory. Recently Lee et al. (1) reported an excellent 10 years intention to treat overall survival in patients with HCC within Milan criteria after first line radiofrequency ablation followed by LT and challenged the alarming study of Llovet et al. about a risk of seeding in patients treated by percutaneous ablation before liver transplantation (2).